We included clinical factors including age at diagnosis, gender, tumor pathological grade, lymph node status, distant metastasis, TNM stage, and gene signatures MAP3K19 and NTSR1 expression (high- and low-expression groups divided by median value). Here, MAP3K19 is linked to neoplasm.